Bacchus at 63 Nears 25 Billion Bottles Sold

by Park Jeongyeon

Published 17 Apr.2026 08:55(KST)

Updated 17 Apr.2026 08:59(KST)

First Domestic Pharmaceutical Product to Surpass Annual Sales of 200 Billion Won
From Pharmacies to Convenience Stores,
From Efficacy Advertising to Empathy Marketing

Dong-A Pharmaceutical's Bacchus is on the verge of surpassing a cumulative sales milestone of 25 billion bottles, 63 years after its launch.

According to industry sources on April 17, as of last year, the cumulative sales of Bacchus reached 24.2 billion bottles. This is an unprecedented figure for a single product by a Korean pharmaceutical company. On average, each Korean has consumed about 470 bottles.

Advertising image for Dong-A Pharmaceutical's fatigue recovery product "Bacchus". Dong-A Pharmaceutical

The fatigue recovery drink Bacchus is effective not only for physical fatigue but also for nutritional disorders, weak constitutions, and loss of strength after illness. In the 1960s, immediately after the Korean War, when the nation was still suffering from poor nutrition, Bacchus drew attention for its convenience of being taken without water and its dual benefits of relieving fatigue and supplementing nutrition.

The growth of Bacchus continued in tandem with Korea’s industrialization. During the rapid economic growth of the 1960s and 1970s, when long working hours were routine, Bacchus became more than just a drink-it established itself as a symbolic product that helped people endure their daily lives.

Advertising strategies also played a crucial role in this process. Rather than directly emphasizing the product’s efficacy, Bacchus commercials featured stories of people enduring everyday fatigue, such as parents and office workers. This approach fostered an emotional connection, positioning Bacchus as a brand that understands its consumers, not just as a beverage.

Changes in distribution channels have also been a key factor in Bacchus's growth. Formerly sold mainly through pharmacies, Bacchus expanded into convenience stores and general retail networks after 2011, significantly improving accessibility. As a result, Dong-A Pharmaceutical became the first Korean pharmaceutical company to achieve annual sales of 200 billion won from a single product.

Product diversification in response to changing consumer trends has continued as well. "Bacchus D" and "Bacchus F" offer different taurine contents, broadening consumer choice. The lineup has expanded to include decaffeinated options, jellies, and even frozen formats.

In particular, the recently launched energy drink "Eolbaksaa" (a combination of ice, Bacchus, and soda) has enjoyed tremendous popularity since its release last year. Within just two months of its launch at GS25 convenience stores, it surpassed cumulative sales of 2.5 million units, ranking first in total beverage sales. In March of this year, the company further expanded the lineup by launching "Eolbaksaa Zero," a sugar-free version that reflects the zero-sugar trend. This strategy has broadened the brand’s appeal from its traditional middle-aged customer base to younger generations.

A Dong-A Pharmaceutical representative stated, "The cumulative sales record of Bacchus carries meaning beyond mere numbers. It reflects the result of Bacchus standing as a symbol of fatigue recovery alongside the daily lives of Koreans for decades," adding, "Bacchus will continue to uphold its brand value as a fatigue recovery drink that is always with you, anytime, anywhere."

Bacchus at 63 Nears 25 Billion Bottles Sold

First Domestic Pharmaceutical Product to Surpass Annual Sales of 200 Billion Won From Pharmacies to Convenience Stores, From Efficacy Advertising to Empathy Marketing

First Domestic Pharmaceutical Product to Surpass Annual Sales of 200 Billion Won
From Pharmacies to Convenience Stores,
From Efficacy Advertising to Empathy Marketing